Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
47.87
+0.02 (0.04%)
At close: Oct 10, 2025, 4:00 PM EDT
47.88
+0.01 (0.02%)
After-hours: Oct 10, 2025, 7:50 PM EDT

Tourmaline Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-88.47-73.21-42.12-19.7-47.83-22.71
Depreciation & Amortization
0.040.040.030.010.620.45
Stock-Based Compensation
1.566.595.770.23.781.02
Other Adjustments
-6.96-7.538.4112.141.130.41
Changes in Accounts Payable
0.512.44-0.040.191.320.1
Changes in Accrued Expenses
3.041.42.330.762.330.96
Changes in Other Operating Activities
-2.6-6.99-2.45-0.05-1.340.56
Operating Cash Flow
-86.28-77.26-28.08-6.46-39.99-19.21
Capital Expenditures
--0.01-0.06-0.07-2.44-1.29
Purchases of Intangible Assets
----5--
Purchases of Investments
-233.35-366.14-16.6--275.88-158.24
Proceeds from Sale of Investments
280.32171.8420.5-181.9326.22
Investing Cash Flow
46.94-194.313.84-5.07-96.39-133.3
Long-Term Debt Issued
---0.25--
Long-Term Debt Repaid
----0.4--
Net Long-Term Debt Issued (Repaid)
----0.15--
Issuance of Common Stock
-161.350.14-140.051.65
Repurchase of Common Stock
--0----
Net Common Stock Issued (Repurchased)
-161.350.14-140.051.65
Issuance of Preferred Stock
--91.8220-115
Net Preferred Stock Issued (Repurchased)
--91.8220-115
Other Financing Activities
--64.75--2.6514.47
Financing Cash Flow
0.61161.35156.7219.85137.4131.12
Net Cash Flow
-38.73-110.22132.488.321.03-21.39
Beginning Cash & Cash Equivalents
70.38140.958.470.1517.5938.98
Ending Cash & Cash Equivalents
31.6530.73140.958.4718.7617.59
Free Cash Flow
-86.28-77.27-28.14-6.53-42.43-20.5
Free Cash Flow Per Share
-3.35-3.05-5.93-7.44-14.57-30.66
Levered Free Cash Flow
-87.48-76.33-42.32-19.01-47.33-21.93
Unlevered Free Cash Flow
-101.45-92.86-45.6-18.86-47.01-21.91
Updated Aug 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q